United States Sterilization Services Market By Technique (Steam, EtO, E-beam radiation, Gamma radiation, Others), By Type (Contract services, Validation services), By Delivery Mode (Onsite, Offsite), By End Use (Hospitals, Pharmaceutical companies, Medical device companies, Clinical laboratories, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 3.83 Billion
CAGR (2026-2031)	7.53%
Fastest Growing Segment	E-beam radiation
Largest Market	North-East
Market Size (2031)	USD 5.92 Billion

Market Overview

The United States Sterilization Services Market will grow from USD 3.83 Billion in 2025 to USD 5.92 Billion by 2031 at a 7.53% CAGR. Sterilization services in the United States healthcare market encompass the critical processes of eliminating all microbial life from medical instruments, devices, and associated materials through various physical and chemical methods such as steam, ethylene oxide, radiation, and hydrogen peroxide gas plasma. This market's expansion is significantly driven by the increasing volume of surgical procedures performed nationally and the persistent need to mitigate healthcare-associated infections. Furthermore, stringent regulatory mandates from bodies like the Food and Medical Device Administration and the growing aging population consistently fuel demand for these essential services. According to the Healthcare Sterile Processing Association, as of December 31, 2025, there were 54,525 active Certified Registered Central Service Technicians, underscoring the professional infrastructure supporting this critical function.

The market also benefits from an escalating trend of outsourcing sterilization activities due to specialized expertise and cost efficiencies. A notable impediment to market expansion remains the intensifying regulatory scrutiny and environmental concerns surrounding ethylene oxide, a widely utilized sterilization agent, which necessitates ongoing investment in alternative technologies and compliance measures.

Key Market Drivers

Infection-control emphasis and HAI reductions drive sterilization demand
The heightened emphasis on infection control and the prevention of healthcare-associated infections (HAIs) stands as a primary catalyst for the United States sterilization services market. Healthcare providers are continuously enhancing protocols to safeguard patient well-being and reduce the financial burdens associated with HAIs. This commitment is reflected in tangible improvements; according to the CDC's 2024 National and State Healthcare-Associated Infections Progress Report, published in January 2026, C. difficile infection decreased by 11% between 2023 and 2024. Such progress necessitates robust and reliable sterilization processes for medical instruments and environments, driving sustained demand for specialized services and innovative decontamination technologies.

Rising surgical volumes and device utilization propel market expansion
Simultaneously, the rising volume of surgical procedures and the escalating utilization of medical devices are significant factors bolstering market expansion. As the population ages and chronic disease prevalence increases, the need for surgical interventions grows, directly correlating with the demand for sterilized equipment. For instance, according to the American Hospital Association's annual "Costs of Caring" report, in March 2026, inpatient volumes in US hospitals rose 5.3% in 2025. Each procedure requires a meticulously sterilized set of instruments, and the increasing complexity of modern medical devices often mandates specialized sterilization methods. Overall, according to the Centers for Medicare & Medicaid Services, in 2025, national health spending reached $5.7 trillion. These trends underscore the indispensable role of sterilization services in supporting the expanding scope of healthcare delivery.

Download Free Sample Report

Key Market Challenges

Regulatory and Environmental Pressures on EtO Sterilization
The intensifying regulatory scrutiny and environmental concerns surrounding ethylene oxide represent a significant impediment to the growth of the United States sterilization services market. Ethylene oxide is a widely utilized sterilization agent, particularly for heat-sensitive medical devices, and the increased oversight directly impacts operational costs and investment requirements. Compliance with evolving environmental regulations, such as those imposed by the Environmental Protection Agency regarding EtO emissions, necessitates substantial capital expenditure for facility upgrades and advanced abatement technologies.

EtO Regulation Drives Adoption of Alternatives and Limits Growth
This heightened regulatory pressure compels sterilization service providers to continuously invest in alternative sterilization technologies, which often entail higher initial costs and require extensive validation processes. The ongoing need for these investments, coupled with potential operational restrictions on EtO use, can limit the capacity for market expansion and innovation in other areas. According to the American Chemistry Council, in March 2025, the association requested a two-year exemption from new EPA rules for its members, a request that could cover 88 ethylene oxide-emitting facilities. The need for such widespread exemptions underscores the substantial compliance burden and potential disruption to operations, directly constraining the profitability and scalability of sterilization services, thereby hampering overall market growth.

Key Market Trends

Growth of Contract Sterilization Outsourcing
A significant trend reshaping the United States Sterilization Services Market is the growing shift towards contract sterilization services. Healthcare facilities and medical device manufacturers are increasingly opting to outsource their sterilization needs to specialized third-party providers. This transition allows them to leverage external expertise, manage escalating operational costs, and navigate complex regulatory landscapes without significant capital investment in in-house infrastructure. This trend is evidenced by the robust performance of leading service providers; for instance, according to BioSpace, February 2026, in "STERIS Announces Financial Results for Fiscal 2026 Third Quarter," STERIS's Applied Sterilization Technologies (AST) segment, which encompasses contract sterilization, reported an 11% increase in revenue to $286.6 million for its fiscal 2026 third quarter, ending December 31, 2025.

Expansion of Low-Temperature Sterilization Technologies
Concurrently, the market is profoundly influenced by the expansion of low-temperature sterilization technologies. Driven by heightened regulatory scrutiny on traditional methods, particularly ethylene oxide emissions, and the increasing sophistication of heat-sensitive medical devices, there is a strong demand for alternative, gentler sterilization solutions. This has spurred investment and adoption of technologies such as hydrogen peroxide gas plasma. This push towards advanced sterilization modalities is further supported by significant investments in the necessary infrastructure and equipment, with STERIS reporting a 103% growth in capital equipment revenue within its Applied Sterilization Technologies segment for the same fiscal 2026 third quarter. This growth reflects the ongoing efforts by service providers and healthcare institutions to upgrade capabilities and broaden the scope of compatible sterilization methods available in the United States.

Segmental Insights

E-beam Radiation: Fastest-Growing, Environmentally Beneficial, and FDA-Endorsed Sterilization Option
In the United States Sterilization Services Market, E-beam radiation stands out as the fastest-growing segment, driven by its significant operational and environmental advantages. This rapid expansion is primarily attributable to E-beam's ability to provide efficient, rapid processing times without the use of hazardous chemicals or radioactive materials, making it a more environmentally sustainable and safer alternative to traditional methods. Furthermore, the U.S. Food and Drug Administration supports and recognizes E-beam as an established sterilization option, with initiatives actively encouraging its adoption for medical devices and pharmaceuticals. This regulatory endorsement, coupled with its product compatibility and residue-free nature, positions E-beam radiation for continued growth.

Regional Insights

North-East Region: Advanced Healthcare Infrastructure and Regulatory Compliance Driving Sterilization Services Demand
The North-East region significantly influences the United States Sterilization Services Market, primarily due to its highly developed healthcare infrastructure. This dominance stems from a high concentration of advanced medical facilities, alongside a substantial presence of pharmaceutical and medical device manufacturing companies in the area. The region's stringent adherence to regulatory standards established by bodies such as the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) necessitates robust and compliant sterilization services to ensure patient safety and reduce healthcare-associated infections. This strong regulatory environment, coupled with ongoing demand from a mature healthcare industry, drives the continuous need for specialized sterilization solutions.

Recent Developments

• In September 2024, BGS Beta-Gamma-Service GmbH & Co. KG (BGS), operating as BGS US LLC, announced the expansion of its facilities in the United States market. The company, headquartered in Pittsburgh, Pennsylvania, initiated the construction of new facilities. These facilities are scheduled to become active in mid-2025 and will provide fully automated e-beam irradiation services to the Northeast United States, catering to the growing demand for advanced sterilization solutions for medical devices.
• In August 2024, Advanced Sterilization Products (ASP), a division of Fortive, obtained FDA clearance for its new ULTRA GI Cycle. This innovative hydrogen peroxide gas plasma sterilization method was developed for reprocessing duodenoscopes, a complex type of medical device. The introduction of the ULTRA GI Cycle into the United States sterilization services market aims to enhance patient safety in healthcare environments by providing an improved high-level sterilization solution for these critical instruments.
• In May 2024, CAI announced a strategic partnership with Fedegari Group, a prominent manufacturer of high-performance sterilization systems. This collaboration aimed to enhance steam sterilization capabilities for the life sciences and biotechnology sectors within the United States. By integrating their respective expertise, CAI and Fedegari sought to streamline sterilization processes, ensuring the safety and efficacy of critical products. This alliance directly contributes to the advancement of sterilization services available to pharmaceutical and medical device manufacturers.
• In March 2024, researchers at Fermilab introduced an advanced electron beam accelerator designed for sterilizing medical equipment. This breakthrough technology utilizes high-energy electron beams to swiftly and sustainably eliminate pathogens. By providing an environmentally conscious alternative to traditional methods, such as ethylene oxide, this development aligns with industry trends towards greener sterilization solutions within the United States sterilization services market. This innovation is expected to offer healthcare providers more efficient and responsible sterilization options, potentially reshaping future market dynamics.

Key Market Players

• STERIS plc
• Sotera Health Company
• 3M Company
• Cantel Medical Corp.
• Advanced Sterilization Products (ASP)
• Getinge AB
• Ecolab Inc.
• Belimed AG
• MMM Group
• Matachana Group

By Technique	By Type	By Delivery Mode	By End Use	By Region
Steam EtO E-beam radiation Gamma radiation Others	Contract services Validation services	Onsite Offsite	Hospitals Pharmaceutical companies Medical device companies Clinical laboratories Others	Northeast Midwest South West

Report Scope:

In this report, the United States Sterilization Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• United States Sterilization Services Market, By Technique:

• Steam
• EtO
• E-beam radiation
• Gamma radiation
• Others

• United States Sterilization Services Market, By Type:

• Contract services
• Validation services

• United States Sterilization Services Market, By Delivery Mode:

• Onsite
• Offsite

• United States Sterilization Services Market, By End Use:

• Hospitals
• Pharmaceutical companies
• Medical device companies
• Clinical laboratories
• Others

• United States Sterilization Services Market, By Region:

• Northeast
• Midwest
• South
• West